ライフサイエンスコーパス: blood group O

1 Ninety-one percent of donors were blood group O.

2 k is significantly reduced in individuals in blood group O.

3 d risk of CVT compared with individuals with blood group O.

4 dney stones and blood group B as compared to blood group O.

5 Majority of study participants were of blood group O (43.2%).

6 an blood samples from adults and newborns of blood groups O, A, and B were treated with either anti-A

7 0.27-0.70) of type 2 diabetes compared with blood group O, adjusting for sE-selectin, sICAM-1, TNF-R

8 bited less human antibody binding than human blood group O allogeneic RBC in 22% of tested sera.

9 e 1998, we transplanted 15 A2 kidneys into 6 blood group O and 9 blood group B patients.

10 previously frozen plasma (four units each of blood group O and A), which can be issued immediately fo

11 f blood group A2 kidneys (20% of group A) to blood group O and B patients expands their potential don

12 the allocation of blood group A2 kidneys for blood group O and B recipients is a practical way to exp

13 nsplantation within 30 days for infants with blood group O and may benefit a broader range of transpl

14 is demonstrated that the association between blood group O and protection from infection with V. chol

15 ion and blood groups A and AB as compared to blood group O and RhD positive as compared to negative.

16 is for understanding the association between blood group O and the risk of infection with V. cholerae

17 The three recipients had blood group O and were in the highest-risk waiting-list

18 risk factor for bleeding in combination with blood group O and/other unknown genetic factors, and (3)

19 rmediate rate (30%) among secretors with non-blood group O, and the highest rate (51%) among secretor

20 Utilization of microarrays populated with blood group O antigens from a diverse array of microbes

21 Individuals with blood group O are more susceptible than other individual

22 P = 1.48x10(-4)) and a protective effect in blood group O as compared with other blood groups (odds

23 l other ABO blood groups as opposed to using blood group O as the reference.

24 The mean wait time of blood group O cadaveric kidney wait list candidates incr

25 Blood group O candidates had higher 2-year mortality (26

26 The wait times of blood group O candidates will not be affected adversely

27 ison with the frameshift deletion underlying blood group O: case-control allelic odds ratio (OR), 1.2

28 predictors of waitlist death/delisting were: blood group O compared to A (subdistribution hazard rati

29 Individuals of blood group O comprised 63.4% of patients, compared with

30 to the Globo H hexaglycosylceramide, i.e. a blood group O determinant on a type 4 core chain, the ge

31 abA-expressing H. pylori strains bind to the blood group O determinants on type 1 core chains, i.e. t

32 iver/small intestinal transplantation with a blood group O donor to a blood type A recipient is descr

33 ood group compatible donors, 100 consecutive blood group O donors, or ten highly selected homozygous

34 and measured with IgG essentially restricted blood group O donors.

35 ssociated with severe malaria, is reduced in blood group O erythrocytes compared with groups A, B, an

36 Patients with blood group O, female patients, older patients, and retr

37 he LewisA antigen and the type II H-antigen (blood group O) for EclA, while related antigens LewisX,

38 th VWF:RCo < 50 U/dL (< 40 for patients with blood group O) fulfilled the acquired von Willebrand syn

39 e falciparum malaria: alpha(+)-thalassaemia, blood group O, G6PD deficiency, and the rs4951074 allele

40 ar disease, with significantly lower risk in blood group O individuals.

41 e generated a series of HLA class I-negative blood group O induced pluripotent stem cell (iPSC) lines

42 O-incompatible listings increased 27 PP, and blood group O infant mortality decreased 13 PP (P < 0.01

43 VWF may still play a role in some cases and blood group O is common.

44 Blood group O is much more common in type 1 von Willebra

45 n the transplant team preferentially selects blood group O living donors and cadaveric kidney allocat

46 candidates will not be affected adversely if blood group O living donors are selected preferentially

47 We hypothesized that blood group O may confer resistance to severe falciparum

48 tes, patients aged 55-65, particularly if of blood group O, may wait >5 years for a donor organ, by w

49 Compared with blood group O, non-O blood groups were associated with h

50 mic equivalents [gEq]) for secretor-positive blood group O or A persons and 7.0 (approximately 2800 g

51 Twenty-one persons were infected (all blood group O or A), and 67% of those infected developed

52 For long-waiting blood group O or B patients, ABOi matches were allowed.

53 tion consists of highly immunized and/or ABO blood group O or B patients.

54 g include those with (i) age >60 years, (ii) blood groups O or B, and (iii) diabetic nephropathy.

55 e younger ( P < 0.001) and more likely to be blood group O ( P < 0.001).

56 Blood group O patients who underwent transplantation wit

57 In blood group O patients, levels of anti-A antibodies were

58 or B patients had lower antibody levels than blood group O patients.

59 ferase-deficient enzyme that encodes the ABO blood group O phenotype previously proposed to protect a

60 were isolated from the small intestine of a blood group O pig and characterized by mass spectrometry

61 Blood group O piglets received kidney allografts from gr

62 el was associated with high SES, white race, blood group O, private insurance, and residence in regio

63 While blood group O protected significantly against infection

64 ransplantation of blood group A2 livers into blood group O recipients is safe and can be performed wi

65 ered more transplant opportunities to women, blood group O recipients, retransplants, and older patie

66 ped to avoid increasing the waiting time for blood group O recipients, we would support the implement

67 n convalescence, and higher in children with blood group O than other children.

68 was significantly greater in volunteers with blood group O than those with non-O blood types (10,353

69 Previous ABO sensitization, donor blood group O to recipient blood group A or B transfer,

70 e samples were collected from a patient with blood group O undergoing antibody removal and subsequent

71 In addition, blood group O VWF demonstrates enhanced susceptibility t

72 proposal would disadvantage cadaveric kidney blood group O wait list candidates, and present an appro

73 t exchanges is the potential to disadvantage blood group O wait list candidates.

74 made the novel observation that persons with blood group O were less likely than those with other blo

75 or studies, however, household contacts with blood group O were more likely to develop severe illness

76 with each group including 2 volunteers with blood group O, were given a dose of 10(5) CFU, and 34 of

77 ible adult patients (aged >/= 18 years) with blood group O+, who required up to two whole blood unit